Ipilimumab: Unique Responses, Toxicities, and Recommendations for the Use of the First Anti–CTLA-4 Therapy in Patients with Melanoma.

Autor: Wong, Michael K.1, Jarkowski III, Anthony2
Zdroj: Journal of Hematology Oncology Pharmacy. Mar2013, Vol. 3 Issue 1, p16-26. 11p.
Databáze: Academic Search Ultimate